Uroporphyria in mice: Thresholds for hepatic CYP1A2 and iron

Ovid Technologies (Wolters Kluwer Health) - Tập 35 Số 4 - Trang 912-921 - 2002
Nadia Nadia, Kerry L. Kerry L., Heidi S. Heidi S., William J. William J., Juliana G. Juliana G., Glenn S. Glenn S., Timothy P. Timothy P., Daniel W. Daniel W., Richard S. Richard S., Jacqueline F. Jacqueline F., Peter R. Peter R.

Tài liệu tham khảo

Elder, 1998, Porphyria cutanea tarda, Semin Liver Dis, 18, 67, 10.1055/s-2007-1007142 Elder, 1998, Alcohol intake and porphyria cutanea tarda, Hepatology, 27, 289, 10.1002/hep.510270142 De Matteis, 1998, Porphyria cutanea tarda of the toxic and sporadic varieties, Clin Dermatol, 16, 265, 10.1016/S0738-081X(97)00206-X Bonkovsky, 1998, Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America, Hepatology, 27, 1661, 10.1002/hep.510270627 Roberts, 1997, Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda, Lancet, 349, 321, 10.1016/S0140-6736(96)09436-6 Sinclair, 2001, Uroporphyria in Hfe mutant mice given 5-aminolevulinate: a new model of Fe-mediated porphyria cutanea tarda, Hepatology, 33, 406, 10.1053/jhep.2001.21409 Phillips, 2001, A mouse model of familial porphyria cutanea tarda, Proc Natl Acad Sci U S A, 98, 259, 10.1073/pnas.98.1.259 Elder, 1978, Heme and Hemoproteins, 157, 10.1007/978-3-642-66763-3_6 Sinclair, 1997, Ascorbic acid deficiency in porphyria cutanea tarda, J Lab Clin Med, 130, 197, 10.1016/S0022-2143(97)90096-2 Sinclair, 1998, Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(−/−) null mutant mice, Biochem J, 330, 149, 10.1042/bj3300149 Sinclair, 2000, CYP1A2 is essential in murine uroporphyria caused by hexachlorobenzene and iron, Toxicol Appl Pharmacol, 162, 60, 10.1006/taap.1999.8832 Smith, 2001, Protection of the Cyp1a2(−/−) null mouse against uroporphyria and hepatic injury following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin, Toxicol Appl Pharmacol, 173, 89, 10.1006/taap.2001.9167 Smith, 1983, Synergism of iron and hexachlorobenzene inhibits hepatic uroporphyrinogen decarboxylase in inbred mice, Biochem J, 214, 909, 10.1042/bj2140909 Smith, 1993, Genetic variation of iron-induced uroporphyria in mice, Biochem J, 291, 29, 10.1042/bj2910029 Constantin, 1996, Uroporphyria induced by 5-aminolaevulinic acid alone in Ahrd SWR mice, Biochem Pharmacol, 52, 1407, 10.1016/S0006-2952(96)00475-3 Akhtar, 1998, Chromosomal linkage analysis of porphyria in mice induced by hexachlorobenzene-iron synergism, Pharmacogenetics, 8, 485, 10.1097/00008571-199812000-00005 Smith, 1998, Comparison of the toxicity of TCDD with AHR-genotype and hepatic CYP1A1 isoforms in iron loaded C57BL/6 × DBA/2 F2 mice, Toxicol Sci, 42, 381 Clothier, 2000, Genetic variation of basal iron status, ferritin and iron regulatory protein in mice: potential for modulation of oxidative stress, Biochem Pharmacol, 59, 115, 10.1016/S0006-2952(99)00306-8 Gorman, 1999, Role of small differences in CYP1A2 in the development of uroporphyria produced by iron and 5-aminolevulinate in C57BL/6 and SWR strains of mice, Biochem Pharmacol, 58, 375, 10.1016/S0006-2952(99)00088-X Liang, 1996, Cyp1a2(−/−) null mutant mice develop normally but show deficient drug metabolism, Proc Natl Acad Sci U S A, 93, 1671, 10.1073/pnas.93.4.1671 Van Birgelen, 1994, Toxic potency of 3,3',4,4',5-pentachlorobiphenyl relative to and in combination with 2,3,7,8-tetrachlorodibenzo-p-dioxin in a subchronic feeding study in the rat, Toxicol Appl Pharmacol, 127, 209, 10.1006/taap.1994.1155 Lambrecht, 1990, Inhibition of uroporphyrinogen decarboxylase activity. The role of cytochrome P450-mediated uroporphyrinogen oxidation, Biochem J, 269, 437, 10.1042/bj2690437 Sinclair, 1984, Inhibition of uroporphyrinogen decarboxylase by halogenated biphenyls in chick hepatocyte cultures, Biochem J, 222, 737, 10.1042/bj2220737 Lowry, 1951, Protein measurement with the Folin phenol reagent, J Biol Chem, 193, 265, 10.1016/S0021-9258(19)52451-6 Sinclair, 1990, Chlorinated biphenyls induce cytochrome P4501A2 and uroporphyrin accumulation in cultures of mouse hepatocytes, Arch Biochem Biophys, 281, 225, 10.1016/0003-9861(90)90436-3 Torrance, 1968, A simple technique for measuring storage iron concentrations in formalinized liver samples, S Afr J Med Sci, 33, 9 Schalinske, 1996, Phosphorylation and activation of both iron regulatory proteins 1 and 2 in HL-60 cells, J Biol Chem, 271, 7168, 10.1074/jbc.271.12.7168 Eisenstein, 2000, Iron regulatory proteins and the molecular control of mammalian iron metabolism, Annu Rev Nutr, 20, 627, 10.1146/annurev.nutr.20.1.627 Chen, 1998, Dietary iron intake rapidly influences iron regulatory proteins, ferritin subunits and mitochondrial aconitase in rat liver, J Nutr, 128, 525, 10.1093/jn/128.3.525 Lipinski, 2000, Intracellular iron status as a hallmark of mammalian cell susceptibility to oxidative stress: a study of L5178Y mouse lymphoma cell lines differentially sensitive to H(2)O(2), Blood, 95, 2960, 10.1182/blood.V95.9.2960.009k13_2960_2966 Wixom, 1980, Hemosiderin: nature, formation, and significance, Int Rev Exp Pathol, 22, 193 Siersema, 1993, Ferritin accumulation and uroporphyrin crystal formation in hepatocytes of C57BL/10 mice: a time-course study, Cell Tissue Res, 274, 405, 10.1007/BF00318759 Smith, 1998, Interaction between iron metabolism and 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice with variants of the Ahr gene: a hepatic oxidative mechanism, Mol Pharmacol, 53, 52, 10.1124/mol.53.1.52 Sweeney, 1979, Iron deficiency prevents liver toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin, Science, 204, 332, 10.1126/science.432648 Sinclair, 1998, Uroporphyrinogen oxidation catalyzed by human cytochromes P450, Drug Metab Dispos, 26, 1019 Sinclair, 1997, Multiple roles of polyhalogenated biphenyls in causing increases in cytochrome P450 and uroporphyrin accumulation in cultured hepatocytes, Toxicol Appl Pharmacol, 174, 171, 10.1006/taap.1997.8273 Nebert, 1996, Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer, DNA Cell Biol, 15, 273, 10.1089/dna.1996.15.273 Christiansen, 2000, Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda, Hum Genet, 107, 612, 10.1007/s004390000415 Bulaj, 2000, Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tarda, J Lab Clin Med, 136, 482, 10.1067/mlc.2000.111024 Bulaj, 2000, Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda, Blood, 95, 1565, 10.1182/blood.V95.5.1565.005k42_1565_1571 Batel, 1995, Relationship between alcohol and tobacco dependencies among alcoholics who smoke, Addiction, 90, 977, 10.1111/j.1360-0443.1995.tb03507.x Brady, 2000, Co-inheritance of mutations in the uroporphyrinogen decarboxylase and haemochromatosis genes accelerates the onset of porphyria cutanea tarda, J Invest Dermatol, 115, 868, 10.1046/j.1523-1747.2000.00148.x Andrews, 2000, Iron homeostasis: insights from genetics and animal models, Nat Rev Genet, 1, 208, 10.1038/35042073